ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Oral Abstract Session

Onco-Nephrology Updates in Practice

October 22, 2020 | 05:00 PM - 07:00 PM

Location: Simulive

Session Description

Oral Abstract Session

Learning Pathway(s)

  • Pathology

Moderator

  • Ala Abudayyeh, MD

Presentations

  • Risk Factors for AKI During Autologous Stem Cell Transplantation in AL Amyloidosis
    05:00 PM - 07:00 PM
    Ralph Nader, MD 
  • Associations Between the Immunoglobulin Germline Gene Usage and the Tropism of Organ Involvement and Renal Amyloid Deposition Patterns in Immunoglobulin Light-Chain Amyloidosis by Mass Spectrometry
    05:00 PM - 07:00 PM
    Dan Yang Li, PhD 
  • Treatment of AL Amyloidosis with Daratumumab Monotherapy
    05:00 PM - 07:00 PM
    Roberta Fenoglio, MD, PhD 
  • Immune Checkpoint Inhibitor Use in Kidney Transplant Recipients: A Multicenter Study
    05:00 PM - 07:00 PM
    Naoka Murakami, MD, PhD, FASN 
  • Daily Caffeine Consumption and Risk of AKI Related to Platinum-Salt Chemotherapy: A Prospective Cohort Study
    05:00 PM - 07:00 PM
    Aghiles Hamroun, MD, MPH 
  • Kidney and Cancer Outcomes with Standard vs. Kidney Protective Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma
    05:00 PM - 07:00 PM
    Gabrielle Côté, MD 
  • Risk Factors for Nephrotoxicity with High-Dose Methotrexate (HDMTX) in Haematological Malignancies
    05:00 PM - 07:00 PM
    Darragh O'Donoghue, MBChB
  • Characterizing the Risk of Development of Proteinuria with Bevacizumab Therapy
    05:00 PM - 07:00 PM
    Tomas Ignacio Guerrero Nunez, MD 
  • CKD Prevalence, Patterns of Treatment, and Outcomes in Patients with Cancer: A Population-Based Cohort Study
    05:00 PM - 07:00 PM
    Abhijat Kitchlu, MD, MS 
  • Assessment of Estimated Glomerular Filtration Rate in a Cohort of 1200 Cancer Patients Using Serum Creatinine and Cystatin C
    05:00 PM - 07:00 PM
    Veronica Torres Costa e Silva, MD, PhD